英文别名Dolutegravir Impurity 7; (3S,7R)-N-benzyl-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide; Desdifluoro dolutegravir; (4R,12aS)-N-Benzyl-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido(1, 2:4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide; 2H-Pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide, 3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-N-(phenylmethyl)-, (4R,12aS)-; Dolutegravir Impurity 5; Dolutegravir Impurity 48; (4R,12aS)-N-benzyl-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide; 2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, 3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-N-(phenylmethyl)-, (4R,12aS)-; GSK 2968451A; Durutevir impurity 11; Desfluoro Dolutegravir/Dolutegravir Impurity C